Yumi Watanabe
Formulating drugs for pediatric and geriatric populations presents unique challenges and considerations in pharmaceutical development. These two distinct patient groups have specific physiological and clinical characteristics that demand drug delivery approaches. This study explores the formulation strategies used to optimize drug delivery for both pediatric and geriatric patients, emphasizing the importance of safety, efficacy, and patient compliance
English 
Spanish 
Chinese 
Russian 
German 
French 
Japanese 
Portuguese 
Telugu